Latest On (BDXA):
General
- Name
- Symbol
- Type
- Exchange
- Currency
- Country
- Last Split Date
Highlights
Share Statistics
- % Held by Insiders <1%
(BDXA) Dividend Calendar:
pays out 0% of its earnings out as a dividend.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
(BDXA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-03-31 | 2020-05-07 | $4.25 billion | $2.55 | $2.32 | 9.91% |
(BDXA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
---|---|---|---|---|---|
Research Development | 264 million | 270 million | 270 million | 282 million | 252 million |
Income Before Tax | 200 million | 394 million | -2 million | 460 million | 3 million |
Selling General Administrative | 1.03 billion | 1.12 billion | 1.1 billion | 1.08 billion | 1.09 billion |
Gross Profit | 1.73 billion | 1.98 billion | 2.27 billion | 2.07 billion | 1.97 billion |
Ebit | 871 million | 1.06 billion | 692 million | 1.19 billion | 737 million |
Operating Income | 444 million | 587 million | 307 million | 716 million | 237 million |
Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
Total Revenue | 4.25 billion | 4.23 billion | 4.58 billion | 4.35 billion | 4.2 billion |
Cost of Revenue | 2.52 billion | 2.25 billion | 2.32 billion | 2.28 billion | 2.22 billion |
Total Other Income Expense Net | -113 million | -59 million | -173 million | -101 million | -81 million |
Net Income From Continuing Operations | 183 million | 277 million | 162 million | 451 million | 20 million |
Net Income Applicable to Common Shares | N/A | N/A | N/A | N/A | N/A |
Cash Flow:
Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
---|---|---|---|---|---|
Investments | -255 million | -287 million | -441 million | -330 million | -269 million |
Change to Liabilities | N/A | N/A | N/A | N/A | N/A |
Total Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
Net Borrowings | N/A | N/A | N/A | N/A | N/A |
Total Cash Flow from Financial Activities | 1.62 billion | -413 million | -925 million | -768 million | -797 million |
Change to Operating Activities | N/A | N/A | N/A | N/A | N/A |
Change in Cash | 1.83 billion | 18 million | -4 million | -173 million | -274 million |
Total Cash from Operating Activities | 482 million | N/A | N/A | N/A | N/A |
Depreciation | 537 million | 530 million | 553 million | 574 million | 563 million |
Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
Change to Inventory | N/A | N/A | N/A | N/A | N/A |
Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
Change to Net Income | N/A | N/A | N/A | N/A | N/A |
Capital Expenditures | 222 million | 173 million | 358 million | 237 million | 195 million |
Balance Sheet:
Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
---|---|---|---|---|---|
Total Liabailities | 32.57 billion | 30.75 billion | 30.68 billion | 30.74 billion | 31.29 billion |
Total Stockholder Equity | 20.95 billion | 21.2 billion | 21.08 billion | 21.5 billion | 21.31 billion |
Other Current Liabilities | N/A | 1000000 | 4.29 billion | N/A | 1000000 |
Total Assets | 53.52 billion | 51.95 billion | 51.77 billion | 52.23 billion | 52.6 billion |
Common Stock | N/A | N/A | N/A | N/A | N/A |
Other Current Assets | 1000000 | N/A | 1000000 | N/A | N/A |
Retained Earnings | 12.87 billion | 12.94 billion | 12.91 billion | 13 billion | 12.79 billion |
Other Liabilities | N/A | N/A | N/A | N/A | N/A |
Other Assets | N/A | N/A | N/A | N/A | N/A |
Cash | 2.35 billion | 560 million | 536 million | 523 million | 686 million |
Total Current Liabilities | 8.76 billion | 6.73 billion | 5.66 billion | 6.24 billion | 7.11 billion |
Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
Property, Plant & Equipment | N/A | N/A | N/A | N/A | N/A |
Total Current Assets | 8.56 billion | 6.44 billion | 6.66 billion | 6.78 billion | 6.84 billion |
Long Term Investments | N/A | N/A | N/A | N/A | N/A |
Net Tangible Assets | N/A | N/A | N/A | N/A | N/A |
Short Term Investments | 6 million | 8 million | 30 million | 12 million | 10 million |
Long Term Debt | 16.81 billion | 16.95 billion | 18.08 billion | 18.02 billion | 17.56 billion |
Inventory | 2.79 billion | 2.76 billion | 2.58 billion | 2.63 billion | 2.63 billion |
Accounts Payable | N/A | N/A | 1.09 billion | N/A | N/A |
(BDXA) Chart:
(BDXA) News:
Below you will find a list of latest news for (BDXA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
(BDXA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
(BDXA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-26 | 11-K | Annual report of employee stock purchase, savings and similar plans | https://www.sec.gov/Archives/edgar/data/10795/000119312520181052/0001193125-20-181052-index.htm |
2020-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000001079520000007/0000010795-20-000007-index.htm |
2020-02-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/10795/000001079520000010/0000010795-20-000010-index.htm |
2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000001079520000013/0000010795-20-000013-index.htm |
2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000001079520000016/0000010795-20-000016-index.htm |
2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/10795/000001079520000019/0000010795-20-000019-index.htm |
2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000001079520000024/0000010795-20-000024-index.htm |
2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/10795/000001079520000027/0000010795-20-000027-index.htm |
2020-10-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000001079520000032/0000010795-20-000032-index.htm |
2020-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000001079520000036/0000010795-20-000036-index.htm |
2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000001079520000040/0000010795-20-000040-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/10795/000008025520000949/0000080255-20-000949-index.htm |
2020-10-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/10795/000008025520001664/0000080255-20-001664-index.htm |
2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/10795/000031506620000831/0000315066-20-000831-index.htm |
2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/10795/000083423720008751/0000834237-20-008751-index.htm |
2020-05-01 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret | https://www.sec.gov/Archives/edgar/data/10795/000087666120000371/0000876661-20-000371-index.htm |
2020-05-29 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/10795/000087666120000456/0000876661-20-000456-index.htm |
2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/10795/000110465920018134/0001104659-20-018134-index.htm |
2020-03-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000114036120006481/0001140361-20-006481-index.htm |
2020-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000114036120007843/0001140361-20-007843-index.htm |
2020-04-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000114036120008843/0001140361-20-008843-index.htm |
2020-05-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/10795/000114036120011219/0001140361-20-011219-index.htm |
2020-05-11 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/10795/000114036120011287/0001140361-20-011287-index.htm |
2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000114036120011484/0001140361-20-011484-index.htm |
2020-05-13 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/10795/000114036120011508/0001140361-20-011508-index.htm |
2020-05-19 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/10795/000114036120011953/0001140361-20-011953-index.htm |
2020-05-19 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/10795/000114036120011954/0001140361-20-011954-index.htm |
2020-05-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000114036120012072/0001140361-20-012072-index.htm |
2020-05-21 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/10795/000114036120012117/0001140361-20-012117-index.htm |
2020-05-22 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/10795/000114036120012349/0001140361-20-012349-index.htm |
2020-05-22 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/10795/000114036120012353/0001140361-20-012353-index.htm |
2020-05-26 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/10795/000114036120012446/0001140361-20-012446-index.htm |
2020-05-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/10795/000114036120012479/0001140361-20-012479-index.htm |
2020-05-28 | SD | https://www.sec.gov/Archives/edgar/data/10795/000119312520154267/0001193125-20-154267-index.htm | |
2020-06-26 | 11-K | Annual report of employee stock purchase, savings and similar plans | https://www.sec.gov/Archives/edgar/data/10795/000119312520180989/0001193125-20-180989-index.htm |
2020-06-26 | 11-K | Annual report of employee stock purchase, savings and similar plans | https://www.sec.gov/Archives/edgar/data/10795/000119312520181052/0001193125-20-181052-index.htm |
2020-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000023/0001543407-20-000023-index.htm |
2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000024/0001543407-20-000024-index.htm |
2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000025/0001543407-20-000025-index.htm |
2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000026/0001543407-20-000026-index.htm |
2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000027/0001543407-20-000027-index.htm |
2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000028/0001543407-20-000028-index.htm |
2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000029/0001543407-20-000029-index.htm |
2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000030/0001543407-20-000030-index.htm |
2020-04-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000031/0001543407-20-000031-index.htm |
2020-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000032/0001543407-20-000032-index.htm |
2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000033/0001543407-20-000033-index.htm |
2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000034/0001543407-20-000034-index.htm |
2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000035/0001543407-20-000035-index.htm |
2020-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000036/0001543407-20-000036-index.htm |
2020-07-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000037/0001543407-20-000037-index.htm |
2020-07-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000038/0001543407-20-000038-index.htm |
2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000039/0001543407-20-000039-index.htm |
2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000040/0001543407-20-000040-index.htm |
2020-09-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000041/0001543407-20-000041-index.htm |
2020-09-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000042/0001543407-20-000042-index.htm |
2020-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000043/0001543407-20-000043-index.htm |
2020-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000044/0001543407-20-000044-index.htm |
2020-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/10795/000154340720000045/0001543407-20-000045-index.htm |
(BDXA) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of (BDXA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: < 1%Institutional Ownership: < 1%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2020-07-09 | Patrick Kaltenbach | EVP & Pres Life Sciences | Sell | 1,272.00 | 260.00 | 330,720.00 | 10,340.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000037/0001543407-20-000037-index.htm |
2020-02-04 | Simon D Campion | EVP and Segment President | Sell | 406.00 | 285.09 | 115,746.54 | 10,773.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000023/0001543407-20-000023-index.htm |
2020-02-04 | Simon D Campion | EVP and Segment President | Sell | 117.00 | 285.09 | 33,355.53 | 11,179.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000023/0001543407-20-000023-index.htm |
2020-02-04 | Simon D Campion | EVP and Segment President | Buy | 523.00 | 63.66 | 33,294.18 | 11,296.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000023/0001543407-20-000023-index.htm |
2020-06-05 | Patrick Kaltenbach | EVP & Pres Life Sciences | Sell | 1,049.00 | 243.20 | 255,116.80 | 11,612.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000036/0001543407-20-000036-index.htm |
2020-02-04 | Simon D Campion | EVP and Segment President | Sell | 1,452.00 | 285.09 | 413,950.68 | 12,212.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000023/0001543407-20-000023-index.htm |
2020-02-04 | Simon D Campion | EVP and Segment President | Sell | 726.00 | 285.09 | 206,975.34 | 12,373.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000023/0001543407-20-000023-index.htm |
2020-02-04 | Simon D Campion | EVP and Segment President | Sell | 1,193.00 | 285.09 | 340,112.37 | 12,669.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000023/0001543407-20-000023-index.htm |
2020-02-04 | Simon D Campion | EVP and Segment President | Buy | 2,326.00 | 88.87 | 206,711.62 | 13,099.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000023/0001543407-20-000023-index.htm |
2020-02-04 | Simon D Campion | EVP and Segment President | Sell | 2,039.00 | 285.09 | 581,298.51 | 13,517.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000023/0001543407-20-000023-index.htm |
2020-02-04 | Simon D Campion | EVP and Segment President | Buy | 2,891.00 | 143.07 | 413,615.37 | 13,664.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000023/0001543407-20-000023-index.htm |
2020-02-04 | Simon D Campion | EVP and Segment President | Buy | 3,089.00 | 110.04 | 339,913.56 | 13,862.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000023/0001543407-20-000023-index.htm |
2020-06-02 | Patrick Kaltenbach | EVP & Pres Life Sciences | Sell | 222.00 | 244.83 | 54,352.26 | 14,688.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000035/0001543407-20-000035-index.htm |
2020-02-04 | Simon D Campion | EVP and Segment President | Buy | 4,783.00 | 121.49 | 581,086.67 | 15,556.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000023/0001543407-20-000023-index.htm |
2020-05-08 | Claire Fraser | Director | Sell | 771.00 | 256.56 | 197,807.76 | 20,168.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000032/0001543407-20-000032-index.htm |
2020-02-11 | Claire Fraser | Director | Sell | 700.00 | 258.70 | 181,090.00 | 20,939.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000024/0001543407-20-000024-index.htm |
2020-02-11 | Claire Fraser | Director | Sell | 800.00 | 258.73 | 206,984.00 | 21,639.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000024/0001543407-20-000024-index.htm |
2020-03-16 | Samrat S. Khichi | EVP and General Counsel | Sell | 4,349.00 | 224.53 | 976,480.97 | 5,262.00 | https://www.sec.gov/Archives/edgar/data/10795/000154340720000030/0001543407-20-000030-index.htm |